Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes.

umibecestat (CNP520) - Novartis, Amgen, Banner Alzheimer’s Institute

amilomotide (CAD106) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/38145469

Ana Graf; Angelika Caputo; Eric M Reiman; Javier Ricart; Jessica B Langbaum; Juha O Rinne; Kathleen Meneses; Marie-Emmanuelle Riviere; Pierre N Tariot; Pilar Cazorla; R Scott Turner; Yihan Sui

Dec 25, 2023